世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033244

世界の閉経後骨粗鬆症の市場規模調査:治療別、流通チャネル別、地域別の予測(2022年〜2028年)

Bizwit Research & Consulting LLP

Global Postmenopausal Osteoporosis Market Size study, by Treatment (Vitamin D, Bisphosphonates, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2028

発刊日 2022/09/15

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000033244

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

閉経後骨粗鬆症の世界市場は、予測期間の2022年から2028年に健全な成長率で成長すると予測されています。骨粗鬆症は、主に閉経後の女性が罹患し、加齢とともに悪化する傾向がある慢性的な骨の病気です。骨密度が低下し、内部の海綿状構造の完全性が急激に低下し、外部からの圧力やひずみに耐えられなくなり、骨が破壊されます。市場成長の原動力は、市場参入企業による投資とそれによる強力なパイプライン、老年人口の増加などの主要な要因です。例えば、WHOによると、2015年から2050年の間に、世界の老年人口(60歳以上の高齢者)の割合は12%から22%へと倍増すると予測されています。その結果、閉経後骨粗鬆症の高齢者(50歳〜60歳)が研究期間中に確実に増えていることがわかりました。さらに、閉経後の女性における骨粗鬆症の危険因子として、加齢、喫煙、アルコール使用、ゴナドトロピン、甲状腺ホルモンの過剰使用、細胞毒性薬剤などの各種疾患治療薬の使用などが挙げられます。2021年に発表された国際更年期学会(IMS)の研究によると、2億人以上の女性が骨粗鬆症であると考えられており、50歳以上の女性の3人に1人が骨粗鬆症による骨折を起こすと予測されているとのことです。また、新製品の上市やより優れた診断ソリューションのための臨床試験の増加により、予測期間中の市場成長率が高まる可能性があります。しかし、閉経後骨粗鬆症の認知度が低いことが、2022年から2028年の予測期間における市場の成長を阻害しています。

閉経後骨粗鬆症の世界市場調査において考慮された主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の世界地域が含まれます。北アメリカは、医療インフラが整備され、診断率や治療率が高いことから、世界市場をリードしています。しかし、アジア太平洋地域は、多くのジェネリック医薬品メーカーが存在し、政府の取り組みや専門家集団の増加により、最も急速に成長している地域と予想されます。

主要企業

  • Amgen Inc.
  • Novartis International AG
  • Merck & Co., Inc
  • Proctor & Gamble Co.
  • Eli Lilly and CO.
  • Enteris BioPharma
  • Pfizer Inc
  • Oncobiologics, Inc.
  • Clonz Biotech
  • Ligand Pharmaceuticals Incorporated

この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。

市場セグメント・サブセグメント

  • 治療別
    ➣ ビタミンD
    ➣ ビスフォスフォネート
    ➣ ホルモン補充療法
    ➣ 副甲状腺ホルモン療法
    ➣ その他
  • 流通チャネル別
    ➣ 病院薬局
    ➣ 小売薬局
    ➣ オンライン薬局
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象の年

  • 実績データ - 2018年、2019年、2020年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2028年

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Postmenopausal Osteoporosis Market, by Region, 2020-2028 (USD Million)
1.2.2. Postmenopausal Osteoporosis Market, by Treatment, 2020-2028 (USD Million)
1.2.3. Postmenopausal Osteoporosis Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Postmenopausal Osteoporosis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Postmenopausal Osteoporosis Market Dynamics
3.1. Postmenopausal Osteoporosis Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Investment by Market Players and Thereby Strong Pipeline
3.1.1.2. Increase in Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Low Awareness of Postmenopausal Osteoporosis
3.1.3. Market Opportunities
3.1.3.1. New Product Launches
3.1.3.2. Increase in Clinical Trails for better diagnostic solutions

Chapter 4. Global Postmenopausal Osteoporosis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Postmenopausal Osteoporosis Market, by Treatment
6.1. Market Snapshot
6.2. Global Postmenopausal Osteoporosis Market by Treatment, Performance - Potential Analysis
6.3. Global Postmenopausal Osteoporosis Market Estimates & Forecasts by Treatment, 2018-2028 (USD Million)
6.4. Postmenopausal Osteoporosis Market, Sub Segment Analysis
6.4.1. Vitamin D
6.4.2. Bisphosphonates
6.4.3. Hormone Replacement Therapy
6.4.4. Parathyroid Hormone Therapy
6.4.5. Others

Chapter 7. Global Postmenopausal Osteoporosis Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Postmenopausal Osteoporosis Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Postmenopausal Osteoporosis Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Million)
7.4. Postmenopausal Osteoporosis Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies

Chapter 8. Global Postmenopausal Osteoporosis Market, Regional Analysis
8.1. Postmenopausal Osteoporosis Market, Regional Market Snapshot
8.2. North America Postmenopausal Osteoporosis Market
8.2.1. U.S. Postmenopausal Osteoporosis Market
8.2.1.1. Treatment breakdown estimates & forecasts, 2018-2028
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Postmenopausal Osteoporosis Market
8.3. Europe Postmenopausal Osteoporosis Market Snapshot
8.3.1. U.K. Postmenopausal Osteoporosis Market
8.3.2. Germany Postmenopausal Osteoporosis Market
8.3.3. France Postmenopausal Osteoporosis Market
8.3.4. Spain Postmenopausal Osteoporosis Market
8.3.5. Italy Postmenopausal Osteoporosis Market
8.3.6. Rest of Europe Postmenopausal Osteoporosis Market
8.4. Asia-Pacific Postmenopausal Osteoporosis Market Snapshot
8.4.1. China Postmenopausal Osteoporosis Market
8.4.2. India Postmenopausal Osteoporosis Market
8.4.3. Japan Postmenopausal Osteoporosis Market
8.4.4. Australia Postmenopausal Osteoporosis Market
8.4.5. South Korea Postmenopausal Osteoporosis Market
8.4.6. Rest of Asia Pacific Postmenopausal Osteoporosis Market
8.5. Latin America Postmenopausal Osteoporosis Market Snapshot
8.5.1. Brazil Postmenopausal Osteoporosis Market
8.5.2. Mexico Postmenopausal Osteoporosis Market
8.6. Rest of The World Postmenopausal Osteoporosis Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Ligand Pharmaceuticals Incorporated
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Amgen Inc.
9.2.3. Novartis International AG
9.2.4. Merck & Co., Inc
9.2.5. Proctor & Gamble Co.
9.2.6. Eli Lilly and CO.
9.2.7. Enteris BioPharma
9.2.8. Pfizer Inc
9.2.9. Oncobiologics, Inc.
9.2.10. Clonz Biotech

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Postmenopausal Osteoporosis Market, report scope
TABLE 2. Global Postmenopausal Osteoporosis Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Postmenopausal Osteoporosis Market estimates & forecasts by Treatment 2018-2028 (USD Million)
TABLE 4. Global Postmenopausal Osteoporosis Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
TABLE 5. Global Postmenopausal Osteoporosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 6. Global Postmenopausal Osteoporosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Postmenopausal Osteoporosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Postmenopausal Osteoporosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Postmenopausal Osteoporosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Postmenopausal Osteoporosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Postmenopausal Osteoporosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Postmenopausal Osteoporosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Postmenopausal Osteoporosis Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Postmenopausal Osteoporosis Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. U.S. Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 17. U.S. Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. Canada Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 19. Canada Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. Canada Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. UK Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 22. UK Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. UK Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. Germany Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 25. Germany Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. Germany Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. RoE Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 28. RoE Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. RoE Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. China Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 31. China Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. China Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. India Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 34. India Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. India Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. Japan Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 37. Japan Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. Japan Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. RoAPAC Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 40. RoAPAC Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. RoAPAC Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. Brazil Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 43. Brazil Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Brazil Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Mexico Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 46. Mexico Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Mexico Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. RoLA Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 49. RoLA Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. RoLA Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. Row Postmenopausal Osteoporosis Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 52. Row Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. Row Postmenopausal Osteoporosis Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. List of secondary sources, used in the study of global Postmenopausal Osteoporosis Market
TABLE 55. List of primary sources, used in the study of global Postmenopausal Osteoporosis Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

List of figures
FIG 1. Global Postmenopausal Osteoporosis Market, research methodology
FIG 2. Global Postmenopausal Osteoporosis Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Postmenopausal Osteoporosis Market, key trends 2021
FIG 5. Global Postmenopausal Osteoporosis Market, growth prospects 2022-2028
FIG 6. Global Postmenopausal Osteoporosis Market, porters 5 force model
FIG 7. Global Postmenopausal Osteoporosis Market, pest analysis
FIG 8. Global Postmenopausal Osteoporosis Market, value chain analysis
FIG 9. Global Postmenopausal Osteoporosis Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Postmenopausal Osteoporosis Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Postmenopausal Osteoporosis Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Postmenopausal Osteoporosis Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Postmenopausal Osteoporosis Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Postmenopausal Osteoporosis Market, regional snapshot 2018 & 2028
FIG 15. North America Postmenopausal Osteoporosis Market 2018 & 2028 (USD Million)
FIG 16. Europe Postmenopausal Osteoporosis Market 2018 & 2028 (USD Million)
FIG 17. Asia Pacific Postmenopausal Osteoporosis Market 2018 & 2028 (USD Million)
FIG 18. Latin America Postmenopausal Osteoporosis Market 2018 & 2028 (USD Million)
FIG 19. Global Postmenopausal Osteoporosis Market, company market share analysis (2021)

この商品のレポートナンバー

0000033244

TOP